drugset / Trial / NCT02036528

Safety and Efficacy of Gentamicin Topical Gel (AppliGel-G) for Treatment of Mild to Moderately Infected Diabetic Foot Ulcers

NCT02036528

Phase 1/2 Terminated 9 enrolled Royer Biomedical, Inc.
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to determine whether AppliGel-G (Gentamicin topical gel) plus oral Ciprofloxacin / Doxycycline are safe and effective in the treatment of mild to moderately infected foot ulcers in diabetic patients.

Timeline

Start
2014-01
Primary completion
2014-12
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Gentamicin Small molecule Topical
Background Ciprofloxacin Small molecule Oral
Background Doxycycline Small molecule Oral

Indications